What is Castle Biosciences's inventories?

Castle Biosciences (CSTL) reported inventories of $10.46M in Q1 2026.

How has Castle Biosciences's inventories changed year-over-year?

Castle Biosciences's inventories increased by 52.7% year-over-year, from $6.85M to $10.46M.

What is the long-term trend for Castle Biosciences's inventories?

Over 5 years (2020 to 2025), Castle Biosciences's inventories has grown at a 35.8% compound annual growth rate (CAGR), from $2.22M to $10.25M.

What does inventories mean?

Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.

Castle Biosciences CSTL Inventories

Inventories at other companies

Labcorp HoldingsLH

$497.7M+1.9%

NeoGenomicsNEO

$29.84M+0.2%

GeneDx HoldingsWGS

$12.24M-3.3%

Adaptive BiotechnologiesADPT

$11.21M+29.0%

BillionToOne, Inc. BLLN

$19.22M+478%

Tempus AI, Inc.TEM

$51.83M+2.7%

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's inventories?: Castle Biosciences (CSTL) reported inventories of $10.46M in Q1 2026.
How has Castle Biosciences's inventories changed year-over-year?: Castle Biosciences's inventories increased by 52.7% year-over-year, from $6.85M to $10.46M.
What is the long-term trend for Castle Biosciences's inventories?: Over 5 years (2020 to 2025), Castle Biosciences's inventories has grown at a 35.8% compound annual growth rate (CAGR), from $2.22M to $10.25M.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.